Cointime

Ingenium Pharmaceuticals AG

company

About

Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.

  • 1 - 10

Highlights

Total Funding Amount
€50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
€50M
Industries
Biotechnology
Founded date
Jan 1, 1997
Number Of Employee
1 - 10
Operating Status
Active

Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€50M
Ingenium Pharmaceuticals AG has raised a total of €50M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2000 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2000 Series B €50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Ingenium Pharmaceuticals AG is funded by 1 investors. Bayern Kapital are the most recent investors.
Investor Name Lead Investor Funding Round
Bayern Kapital — Series B
Cointime
เนื้อหา
บริษัท